TY - JOUR T1 - Payer decision-making with limited comparative and cost effectiveness data: the case of new pharmacological treatments for gout JF - Evidence Based Medicine JO - Evid Based Med SP - 105 LP - 108 DO - 10.1136/ebmed-2011-100065 VL - 17 IS - 4 AU - Michele Meltzer AU - Laura T Pizzi AU - Eric Jutkowitz Y1 - 2012/08/01 UR - http://ebm.bmj.com/content/17/4/105.abstract N2 - ER -